Drug Shortage Report for ADENOSINE INJECTION
| Report ID | 252332 |
| Drug Identification Number | 02457474 |
| Brand name | ADENOSINE INJECTION |
| Common or Proper name | ADENOSINE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ADENOSINE |
| Strength(s) | 3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 2mL |
| ATC code | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-05-03 |
| Actual start date | |
| Estimated end date | 2025-05-26 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-04 |
| Company comments | Fresenius Kabi Canada regrets to advise that our Adenosine Injection 3 mg/mL prefilled syringe 2 mL may be facing a backorder. During this time, our Adenosine Injection 3 mg/mL SD Vial 2 mL will be available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-05-04 | English | Compare |
| v4 | 2025-04-16 | French | Compare |
| v3 | 2025-04-16 | English | Compare |
| v2 | 2025-03-11 | French | Compare |
| v1 | 2025-03-11 | English | Compare |
Showing 1 to 5 of 5